OncoSec Announces that Shareholders Have Approved CGP/Sirtex Transaction
SAN DIEGO & PENNINGTON, N.J.–(BUSINESS WIRE)–OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies,…